Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-07-01 19:30:11 ET · period of report 2026-07-01 · accession 0001193125-26-292985 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-01 19:30 | 2026-07-01 | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $4.95 | +49.7K | 56.9K | +687% | +$245.8K |
| DT | 2026-07-01 19:30 | 2026-07-01 | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $240.25 | -49.7K | 7,229 | -87% | -$11.93M |
| DT | 2026-07-01 19:30 | 2026-07-01 | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -49.7K | 49.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | M | A | 49,666 | $4.95 | 56,895 | D | — | — | (F1) Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. |
| 2 | Common | Common Stock | 2026-07-01 | S | D | 49,666 | $240.25 | 7,229 | D | — | — | (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. (F3) Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $237.64 and $244.71. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 49,666 | $0.00 | 49,664 | D | $240.25 · 2018-03-15 to 2027-03-15 | 49,666 Common Stock | (F1) Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. |